Member Info for EarlofAim

what a fantastic position to be in

take a look at this!!

unbelievable that NXP002 has the potential to treat.

https://www.google.com/amp/s/www.thesun.co.uk/news/uknews/13205667/nhs-long-covid-mini-hospitals/amp/

this staggering 500,000 patients stuffing from Long covid1l

markets missing this big time
Google 'NHS Longcovid

#LongCovid is on all the online media now.

I think NUFORMIX has the the answer to the Long covid problem, so damage lungs from Covid-19 and other Lung diseases. this puts NXP002 right at the centre of the treatment.

Dr Blackwell can't keep silence for ever, surely he will have to put an Rns out.

dragonsoup
someone on twitter said about Moderna tech, u asked him what to do mean?
still waiting for the answer, in the mean time, I thought I'll ask any of you guys.
anyways what ever NUFORMIX had in store for us will come or else just hold till something comes up.

I am not making things up, all I asked who's tech Moderna using? did you not see my question mark.
I didn't say Moderna are using NUFORMIX tech.
anyways let see what happens on here rest of the week

who's technology Moderna used is the big question?
could it be any of NUFORMIX tech?
would be nice if they did.

Moderna scientists used an innovative technique for developing the vaccine so quickly

#NFX
@NuformixPlc
Dr Blackwell said "NXP002 has Phenomenal opportunity to treat Lungs disease and Covid19 complications"

#sng done well recently, now its #NFX time

however research before this slips out your sight

all the winners

you said something very profound
'yep could be the last time we ses #NFX at this level 2.85
GLA and Dyor
I'm convinced myself something next week.

huge link here
when rns lands all sellers would be kicking themselves

https://www.news-medical.net/amp/news/20201030/SARS-CoV-2-viroporin-triggers-NLRP3-inflammasome-causing-a-severe-inflammatory-response.aspx

soup dragon
in the end all medicinal properties comes from somewhere it how the producers produce it.
your statement is like saying metals making cars???

look at the science behind it and that's what matters.
GLA and that short lives rise proves that this will move when rns lands.

this is the beginning of something special, look at this report.

https://onlinelibrary.wiley.com/doi/full/10.1111/bcpt.13503#

https://onlinelibrary.wiley.com/doi/full/10.1111/bcpt.13503#

sorry guys for the double post

now take a look at the recent articles on NLRP3,
this would be huge

The Board has previously confirmed, in conjunction with its network of key opinion leaders, that it had started to review and assess emerging academic data that suggests coronaviruses can trigger hyperinflammation through activation of the biological target known as the NLRP3 inflammasome, making NXP002 a potential novel drug target to treat Covid-19. This, together with potential future licensing opportunities for NXP002 in both IPF and Covid-19, makes it important to explore all licensing possibilities to maximise value for shareholders.

taken from October 7 Rns

The Board has previously confirmed, in conjunction with its network of key opinion leaders, that it had started to review and assess emerging academic data that suggests coronaviruses can trigger hyperinflammation through activation of the biological target known as the NLRP3 inflammasome, making NXP002 a potential novel drug target to treat Covid-19. This, together with potential future licensing opportunities for NXP002 in both IPF and Covid-19, makes it important to explore all licensing possibilities to maximise value for shareholders.